• Filing Date: 2020-11-03
  • Form Type: 10-Q
  • Description: Quarterly report
v3.20.2
Condensed Consolidated Statements Of Changes in Shareholders' (Deficit) Equity - USD ($)
$ in Thousands
Common Stock
Preferred Stock
Series A convertible preferred stock
Preferred Stock
Series C convertible preferred stock
Additional Paid-In Capital
Common Stock Warrants
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total
Beginning balance (in shares) at Dec. 31, 2018 4,671,921 600,000 10,150          
Beginning balance at Dec. 31, 2018 $ 47 $ 19,227 $ 11,117 $ 346,762 $ 3,707 $ (377,127) $ (1,011) $ 2,722
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock, net of issuance costs (in shares) 59,319              
Issuance of common stock, net of issuance costs
Stock-based compensation expense 770 770
Net loss (2,763) (2,763)
Foreign currency translation adjustments (83) (83)
Ending balance (in shares) at Mar. 31, 2019 4,731,240 600,000 10,150          
Ending balance at Mar. 31, 2019 $ 47 $ 19,227 $ 11,117 347,532 3,707 (379,890) (1,094) 646
Beginning balance (in shares) at Dec. 31, 2018 4,671,921 600,000 10,150          
Beginning balance at Dec. 31, 2018 $ 47 $ 19,227 $ 11,117 346,762 3,707 (377,127) (1,011) $ 2,722
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercise of stock options (in shares)              
Net loss               $ (10,941)
Foreign currency translation adjustments               (193)
Ending balance (in shares) at Sep. 30, 2019 4,734,382 600,000 10,150          
Ending balance at Sep. 30, 2019 $ 47 $ 19,227 $ 11,117 348,698 3,707 (388,068) (1,204) (6,476)
Beginning balance (in shares) at Mar. 31, 2019 4,731,240 600,000 10,150          
Beginning balance at Mar. 31, 2019 $ 47 $ 19,227 $ 11,117 347,532 3,707 (379,890) (1,094) 646
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock, net of issuance costs (in shares) 2,124          
Issuance of common stock, net of issuance costs
Stock-based compensation expense 655 655
Net loss (5,038) (5,038)
Foreign currency translation adjustments 55 55
Ending balance (in shares) at Jun. 30, 2019 4,733,364 600,000 10,150          
Ending balance at Jun. 30, 2019 $ 47 $ 19,227 $ 11,117 348,187 3,707 (384,928) (1,039) (3,682)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock, net of issuance costs (in shares) 1,018              
Issuance of common stock, net of issuance costs 7 $ 7
Exercise of stock options (in shares)              
Stock-based compensation expense 504 $ 504
Net loss (3,140) (3,140)
Foreign currency translation adjustments (165) (165)
Ending balance (in shares) at Sep. 30, 2019 4,734,382 600,000 10,150          
Ending balance at Sep. 30, 2019 $ 47 $ 19,227 $ 11,117 348,698 3,707 (388,068) (1,204) (6,476)
Beginning balance (in shares) at Dec. 31, 2019 4,965,949 600,000 10,150          
Beginning balance at Dec. 31, 2019 $ 50 $ 19,227 $ 11,117 350,117 3,707 (387,570) (1,093) (4,445)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock, net of issuance costs (in shares) 62,933              
Issuance of common stock, net of issuance costs
Stock-based compensation expense 440 440
Other (115) (115)
Net loss (1,198) (1,198)
Foreign currency translation adjustments (86) (86)
Ending balance (in shares) at Mar. 31, 2020 5,028,882 600,000 10,150          
Ending balance at Mar. 31, 2020 $ 50 $ 19,227 $ 11,117 350,442 3,707 (388,768) (1,179) (5,404)
Beginning balance (in shares) at Dec. 31, 2019 4,965,949 600,000 10,150          
Beginning balance at Dec. 31, 2019 $ 50 $ 19,227 $ 11,117 350,117 3,707 (387,570) (1,093) $ (4,445)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercise of stock options (in shares)              
Net loss               $ (4,362)
Foreign currency translation adjustments               205
Ending balance (in shares) at Sep. 30, 2020 5,131,744 600,000 8,650          
Ending balance at Sep. 30, 2020 $ 51 $ 19,227 $ 9,474 352,728 3,707 (391,932) (888) (7,633)
Beginning balance (in shares) at Mar. 31, 2020 5,028,882 600,000 10,150          
Beginning balance at Mar. 31, 2020 $ 50 $ 19,227 $ 11,117 350,442 3,707 (388,768) (1,179) (5,404)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock, net of issuance costs (in shares) 2,863              
Issuance of common stock, net of issuance costs 10 10
Stock-based compensation expense 317 317
Net loss (2,546) (2,546)
Foreign currency translation adjustments 93 93
Ending balance (in shares) at Jun. 30, 2020 5,031,745 600,000 10,150          
Ending balance at Jun. 30, 2020 $ 50 $ 19,227 $ 11,117 350,769 3,707 (391,314) (1,086) $ (7,530)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercise of stock options (in shares)              
Preferred stock conversion (in shares) 99,999 (1,500)          
Preferred stock conversion $ 1 $ (1,643) 1,642
Stock-based compensation expense 317 317
Net loss (618) (618)
Foreign currency translation adjustments 198 198
Ending balance (in shares) at Sep. 30, 2020 5,131,744 600,000 8,650          
Ending balance at Sep. 30, 2020 $ 51 $ 19,227 $ 9,474 $ 352,728 $ 3,707 $ (391,932) $ (888) $ (7,633)